LMR Partners’s Epizyme, Inc EPZM Stock Holding History

LMR Partners’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-68,156	Closed	-$100K	–	1375
2022 Q2	$100K	Buy	+68,156	New	+$50.1K	﹤0.01%	1099

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

LMR Partners's EPZM Position: Q3 2022 in Review

LMR Partners sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 68,156 shares — an estimated $100K sold.

LMR Partners first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $100K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

LMR Partners reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
LMR Partners sold 68,156 Epizyme, Inc shares in Q3 2022, an estimated $100K.
LMR Partners first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
LMR Partners's Epizyme, Inc position peaked at $100K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.